Prophylactic platelet transfusion

New England Journal of Medicine

Volumn 369, Issue 6, 2013, Pages 577-578

  Wandt, Hannes ^a   Schäfer Eckart, Kerstin ^a   Ehninger, Gerhard ^b  

^a KLINIKUM NÜRNBERG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTRANSPLANTATION; BLEEDING; HUMAN; LETTER; LEUKEMIA; PATIENT SAFETY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; THROMBOCYTE TRANSFUSION; CLINICAL EFFECTIVENESS; ERYTHROCYTE TRANSFUSION;

EID: 84881239173     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1307163     Document Type: Letter

References (5)

1. Wandt H, Schaefer-Eckart K, Wendelin K, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012;380:1309-16.
2. Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013;368:1771-80.
3. Wandt H, Schaefer-Eckart K, Frank M, Birkmann J, Wilhelm M. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006;37:387-92. (Pubitemid 43250473)
4. Blumberg N, Heal JM, Phillips GL, Phipps RP. Platelets - to transfuse or not to transfuse. Lancet 2012;380:1287-9.
5. Slichter SJ. Eliminate prophylactic platelet transfusions? N Engl J Med 2013;368:1837-8.